Global Fractional Flow Reserve Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). FFR is a novel and potentially clinically useful mathematical solution for estimation of stenotic coronary artery atherosclerosis. Reliability/collaborative measurement between capable laboratories in measuring this essential metric appears muddled in a proprietary race to claim cardiac mathematics dedicated to risk in ischemic cardiac disease. Proprietary claims of cardiac mathematics have not been previously argued in patent law. Fractional flow reserve is defined as the pressure after (distal to) a stenosis relative to the pressure before the stenosis. The result is an absolute number; an FFR of 0.80 means that a given stenosis causes a 20% drop in blood pressure. In other words, FFR expresses the maximal flow down a vessel in the presence of a stenosis compared to the maximal flow in the hypothetical absence of the stenosis. This report studies the device for Fractional Flow Reserve.
According to our (Global Info Research) latest study, the global Fractional Flow Reserve market size was valued at US$ 1042 million in 2023 and is forecast to a readjusted size of USD 2145 million by 2030 with a CAGR of 11.0% during review period.
Global Fractional Flow Reserve key players include Philips, Abbott, Boston Scientific, Bracco, Opsens, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 25 percent. In terms of application, the largest application is Multi-vessel disease, occupied for a share of 63%.
This report is a detailed and comprehensive analysis for global Fractional Flow Reserve market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Fractional Flow Reserve market size and forecasts, in consumption value ($ Million), 2019-2030
Global Fractional Flow Reserve market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Fractional Flow Reserve market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Fractional Flow Reserve market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fractional Flow Reserve
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fractional Flow Reserve market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Philips, Abbott, Boston Scientific, Bracco, Opsens, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Fractional Flow Reserve market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Fractional Flow Reserve market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Type 1
Type 2
Market segment by Application
Multi-vessel Disease
Single-vessel Disease
Market segment by players, this report covers
Philips
Abbott
Boston Scientific
Bracco
Opsens
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Fractional Flow Reserve product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Fractional Flow Reserve, with revenue, gross margin, and global market share of Fractional Flow Reserve from 2019 to 2024.
Chapter 3, the Fractional Flow Reserve competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Fractional Flow Reserve market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fractional Flow Reserve.
Chapter 13, to describe Fractional Flow Reserve research findings and conclusion.